246 related articles for article (PubMed ID: 24281461)
21. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide and thalidomide analogues for induction of remission in Crohn's disease.
Srinivasan R; Akobeng AK
Cochrane Database Syst Rev; 2009 Apr; (2):CD007350. PubMed ID: 19370684
[TBL] [Abstract][Full Text] [Related]
23. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Sandborn WJ; Hanauer SB; Rutgeerts P; Fedorak RN; Lukas M; MacIntosh DG; Panaccione R; Wolf D; Kent JD; Bittle B; Li J; Pollack PF
Gut; 2007 Sep; 56(9):1232-9. PubMed ID: 17299059
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
25. [Thalidomide in refractory Crohn's disease: long-term efficacy and safety].
Xu S; Zu XM; Feng R; Zhang SH; Qiu Y; Chen BL; Zeng ZR; Chen MH; He Y
Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):445-450. PubMed ID: 32486585
[No Abstract] [Full Text] [Related]
26. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
[TBL] [Abstract][Full Text] [Related]
27. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Colombel JF; Sandborn WJ; Rutgeerts P; Enns R; Hanauer SB; Panaccione R; Schreiber S; Byczkowski D; Li J; Kent JD; Pollack PF
Gastroenterology; 2007 Jan; 132(1):52-65. PubMed ID: 17241859
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of thalidomide in refractory Crohn's disease.
Gerich ME; Yoon JL; Targan SR; Ippoliti AF; Vasiliauskas EA
Aliment Pharmacol Ther; 2015 Mar; 41(5):429-37. PubMed ID: 25511905
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
Mahdi G; Israel DM; Hassall E
Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
[TBL] [Abstract][Full Text] [Related]
30. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
31. Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ; Gasink C; Gao LL; Blank MA; Johanns J; Guzzo C; Sands BE; Hanauer SB; Targan S; Rutgeerts P; Ghosh S; de Villiers WJ; Panaccione R; Greenberg G; Schreiber S; Lichtiger S; Feagan BG;
N Engl J Med; 2012 Oct; 367(16):1519-28. PubMed ID: 23075178
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic review.
Qiu T; Li H; Sun T; Men P; Cui X; Liu C; Zhai S
J Clin Pharm Ther; 2020 Oct; 45(5):1134-1142. PubMed ID: 32743898
[TBL] [Abstract][Full Text] [Related]
33. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I; Rachmilewitz D; Schreiber S; Eliakim R; van der Woude CJ; Kornbluth A; Buchman AL; Bar-Meir S; Bokemeyer B; Goldin E; Maaser C; Mahadevan U; Seidler U; Hoffman JC; Homoky D; Plasse T; Powers B; Rutgeerts P; Hommes D;
Gut; 2010 Jun; 59(6):760-6. PubMed ID: 20551461
[TBL] [Abstract][Full Text] [Related]
34. Certolizumab pegol for the treatment of Crohn's disease.
Sandborn WJ; Feagan BG; Stoinov S; Honiball PJ; Rutgeerts P; Mason D; Bloomfield R; Schreiber S;
N Engl J Med; 2007 Jul; 357(3):228-38. PubMed ID: 17634458
[TBL] [Abstract][Full Text] [Related]
35. Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.
Hawkey CJ; Allez M; Clark MM; Labopin M; Lindsay JO; Ricart E; Rogler G; Rovira M; Satsangi J; Danese S; Russell N; Gribben J; Johnson P; Larghero J; Thieblemont C; Ardizzone S; Dierickx D; Ibatici A; Littlewood T; Onida F; Schanz U; Vermeire S; Colombel JF; Jouet JP; Clark E; Saccardi R; Tyndall A; Travis S; Farge D
JAMA; 2015 Dec; 314(23):2524-34. PubMed ID: 26670970
[TBL] [Abstract][Full Text] [Related]
36. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients.
Zhu Z; Li M; Shu X; Bai A; Long S; Liu D; Lu N; Zhu X; Liao W
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):210-216. PubMed ID: 27836485
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide Celgene Corp.
Bruyn GA
IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents.
Liew WK; Pacak CA; Visyak N; Darras BT; Bousvaros A; Kang PB
J Pediatr; 2016 Nov; 178():227-232. PubMed ID: 27567409
[TBL] [Abstract][Full Text] [Related]
40. Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease.
Simon M; Pariente B; Lambert J; Cosnes J; Bouhnik Y; Marteau P; Allez M; Colombel JF; Gornet JM
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):966-972.e2. PubMed ID: 26598226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
